Product Information
BUPRENORPHINE 7.5 MCG/HR PATCH is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $34.0243 per EA under NDC 00093323940. Its NADAC has been published 209 times since Jun 29, 2022.
Strength
7.5 ug/h
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093323940
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINEApproval Type
Generic (ANDA)
FDA Application
ANDA204937On Market Since
12/27/2021
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 7.5 MCG/HR PATCH has been published 209 times since Jun 29, 2022, and over the history we have for it it has declined 31.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $34.0243 per EA |
|---|---|
| All-time high | $62.8423 (Jan 11, 2023) |
| All-time low | $25.3493 (Nov 20, 2024) |
| 52-week high | $36.1665 |
| 52-week low | $30.1197 |
| Median price | $36.1665 |
| Average price | $39.9489 |
| Largest weekly change | +34.4% (Dec 21, 2022) |
| Weeks tracked | 209 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 7.5 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 7.5 MCG/HR PATCH, manufactured by Teva Pharmaceuticals USA Inc., is $34.0243 per EA (NDC 00093323940), effective Jun 24, 2026.
How has the price of BUPRENORPHINE 7.5 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 7.5 MCG/HR PATCH has declined 31.9%. It has been tracked across 209 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 7.5 MCG/HR PATCH?
Since Jun 29, 2022, the NADAC for BUPRENORPHINE 7.5 MCG/HR PATCH has ranged from a low of $25.3493 (Nov 20, 2024) to a high of $62.8423 (Jan 11, 2023), with a median of $36.1665 per EA.
Are there cheaper alternatives to BUPRENORPHINE 7.5 MCG/HR PATCH?
3 NADAC-published products share the same active ingredient, strength, and dosage form as BUPRENORPHINE 7.5 MCG/HR PATCH, but none are currently priced below it.
Who manufactures BUPRENORPHINE 7.5 MCG/HR PATCH?
BUPRENORPHINE 7.5 MCG/HR PATCH (NDC 00093323940) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification